A carregar...
Initial inhaler choice in COPD: real-world evidence
In a real-world cohort (UK's CPRD), initiating inhaled treatment for COPD with ICS/LABA rather than LAMA improves exacerbation rate without significant increases in pneumonia rates in those with peripheral blood eosinophil counts >4% http://bit.ly/2OZpij5
Na minha lista:
| Publicado no: | Breathe (Sheff) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
European Respiratory Society
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6885333/ https://ncbi.nlm.nih.gov/pubmed/31803273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.0256-2019 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|